BACKIBD Location
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 19 April 2025]
We are inviting expressions of interest (EoI) for commercializing “IBD Location” technology. The innovation is developed by Professor NG Siew Chien, Professor of Department of Medicine & Therapeutics of The Chinese University of Hong Kong (CUHK Reference: 25/MED/1499).
The Technology
Inflammatory bowel disease (IBD) has historically been classified into Ulcerative colitis (UC) and Crohn’s disease (CD). This invention provide a more nuanced classification based on the site of initial onset.
Commercialization
The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus.
This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and the University is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration.
IBD Location
[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 19 April 2025]
We are inviting expressions of interest (EoI) for commercializing “IBD Location” technology. The innovation is developed by Professor NG Siew Chien, Professor of Department of Medicine & Therapeutics of The Chinese University of Hong Kong (CUHK Reference: 25/MED/1499).
The Technology
Inflammatory bowel disease (IBD) has historically been classified into Ulcerative colitis (UC) and Crohn’s disease (CD). This invention provide a more nuanced classification based on the site of initial onset.
Commercialization
The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus.
This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and the University is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration.